Terms: = Lung cancer AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA
17 results:
1. Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC.
Gémes N; Balog JÁ; Neuperger P; Schlegl E; Barta I; Fillinger J; Antus B; Zvara Á; Hegedűs Z; Czimmerer Z; Manczinger M; Balogh GM; Tóvári J; Puskás LG; Szebeni GJ
Front Immunol; 2023; 14():1297577. PubMed ID: 38187374
[TBL] [Abstract] [Full Text] [Related]
2. Anti-hvem mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human hvem and BTLA molecules challenged with hvem expressing tumors.
Demerlé C; Gorvel L; Mello M; Pastor S; Degos C; Zarubica A; Angelis F; Fiore F; Nunes JA; Malissen B; Greillier L; Guittard G; Luche H; Barlesi F; Olive D
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37230538
[TBL] [Abstract] [Full Text] [Related]
3. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma.
Wei S; Lu K; Xing J; Yu W
FASEB J; 2023 Apr; 37(4):e22849. PubMed ID: 36884358
[TBL] [Abstract] [Full Text] [Related]
4. Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell lung cancer.
Wang Q; He Y; Li W; Xu X; Hu Q; Bian Z; Xu A; Tu H; Wu M; Wu X
Front Immunol; 2022; 13():887916. PubMed ID: 35874720
[TBL] [Abstract] [Full Text] [Related]
5. LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
Yoo KJ; Johannes K; González LE; Patel A; Shuptrine CW; Opheim Z; Lenz K; Campbell K; Nguyen TA; Miriyala J; Smith C; McGuire A; Tsai YH; Rangwala F; de Silva S; Schreiber TH; Fromm G
J Immunol; 2022 Aug; 209(3):510-525. PubMed ID: 35817517
[TBL] [Abstract] [Full Text] [Related]
6. The Role of B and T Lymphocyte Attenuator in Respiratory System Diseases.
Deng Z; Zheng Y; Cai P; Zheng Z
Front Immunol; 2021; 12():635623. PubMed ID: 34163466
[TBL] [Abstract] [Full Text] [Related]
7. The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands.
de Ruiter JC; Heineman DJ; Daniels JM; van Diessen JN; Damhuis RA; Hartemink KJ
Lung Cancer; 2020 Jun; 144():64-70. PubMed ID: 32371262
[TBL] [Abstract] [Full Text] [Related]
8. The immune checkpoint, hvem may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.
Ren S; Tian Q; Amar N; Yu H; Rivard CJ; Caldwell C; Ng TL; Tu M; Liu Y; Gao D; Ellison K; Suda K; Rozeboom L; Rivalland G; Mitchell P; Zhou C; Hirsch FR
Lung Cancer; 2018 Nov; 125():115-120. PubMed ID: 30429008
[TBL] [Abstract] [Full Text] [Related]
9. tr2 and TR4 Orphan Nuclear Receptors: An Overview.
Lin SJ; Yang DR; Yang G; Lin CY; Chang HC; Li G; Chang C
Curr Top Dev Biol; 2017; 125():357-373. PubMed ID: 28527578
[TBL] [Abstract] [Full Text] [Related]
10. Resolution of oxidative stress by thioredoxin reductase: Cysteine versus selenocysteine.
Cunniff B; Snider GW; Fredette N; Stumpff J; Hondal RJ; Heintz NH
Redox Biol; 2014; 2():475-84. PubMed ID: 24624337
[TBL] [Abstract] [Full Text] [Related]
11. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2.
Fang F; Zheng Q; Zhang J; Dong B; Zhu S; Huang X; Wang Y; Zhao B; Li S; Xiong H; Chen J; Wu N; Song SW; Chang C; Yang Y
Oncol Rep; 2013 Jan; 29(1):297-305. PubMed ID: 23129017
[TBL] [Abstract] [Full Text] [Related]
12. Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells.
Newick K; Cunniff B; Preston K; Held P; Arbiser J; Pass H; Mossman B; Shukla A; Heintz N
PLoS One; 2012; 7(6):e39404. PubMed ID: 22761781
[TBL] [Abstract] [Full Text] [Related]
13. Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer.
Economidou F; Antoniou KM; Soufla G; Lasithiotaki I; Karagiannis K; Lymbouridou R; Proklou A; Spandidos DA; Siafakas NM
J Recept Signal Transduct Res; 2010 Jun; 30(3):154-60. PubMed ID: 20196627
[TBL] [Abstract] [Full Text] [Related]
14. Modulation of T cell proliferation through the LIGHT-hvem-BTLA cosignaling pathway.
Cheung TC
Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
[TBL] [Abstract] [Full Text] [Related]
15. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells.
Wang XF; Chen YJ; Wang Q; Ge Y; Dai Q; Yang KF; Fang-Xie ; Zhou YH; Hu YM; Mao YX; Zhang XG
Tissue Antigens; 2007 Feb; 69(2):145-53. PubMed ID: 17257317
[TBL] [Abstract] [Full Text] [Related]
16. Expression of TRAIL and TRAIL receptors in normal and malignant tissues.
Daniels RA; Turley H; Kimberley FC; Liu XS; Mongkolsapaya J; Ch'En P; Xu XN; Jin BQ; Pezzella F; Screaton GR
Cell Res; 2005 Jun; 15(6):430-8. PubMed ID: 15987601
[TBL] [Abstract] [Full Text] [Related]
17. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
[TBL] [Abstract] [Full Text] [Related]
